NCT06666816 Observational Study to Observe Variations of Gait Parameters in Patients With Neuromuscular Diseases
| NCT ID | NCT06666816 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Eugenio Medea |
| Condition | Muscular Dystrophies |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2017-10-27 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2017-10-27 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study has the general objective of observing walking parameters during a clinical test to objectively estimate fatigue in patients with neuromuscular diseases. Furthermore, the investigators want to evaluate the feasibility of collecting physical activity in daily life conditions during a one-week monitoring period using a wearable sensor.
Eligibility Criteria
Inclusion Criteria: * Ambulant adult patients with genetic diagnosis of muscular dystrophy/myopathy (dystrophinopathies, muscular dystrophies and congenital and non-congenital myopathies), of spinal muscular atrophy (SMA) and with molecular diagnosis of Charcot-Marie Tooth 1 or 2. * independent walking, even with assistance; Exclusion Criteria: * Dilated or ischemic heart disease with moderate impairment; * Chronic respiratory failure: forced vital capacity (FVC) \< 40%; more than 5% of nocturnal time spent with peripheral oxygen saturation levels \< 90.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06666816 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Muscular Dystrophies. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06666816 currently recruiting?
Yes, NCT06666816 is actively recruiting participants. Contact the research team at fabio.storm@lanostrafamiglia.it for enrollment information.
Where is the NCT06666816 trial being conducted?
This trial is being conducted at Bosisio Parini, Italy, Conegliano, Italy.
Who is sponsoring the NCT06666816 clinical trial?
NCT06666816 is sponsored by IRCCS Eugenio Medea. The trial plans to enroll 120 participants.